Free Trial

Theravance Biopharma (TBPH) SEC Filings & 10K Form

Theravance Biopharma logo
$8.93 -0.30 (-3.25%)
Closing price 04:00 PM Eastern
Extended Trading
$8.96 +0.04 (+0.39%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Theravance Biopharma SEC Filings

DateFilerForm TypeView
03/07/2025
5:15 AM
Theravance Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
5:17 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:07 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:09 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:11 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:05 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:24 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:26 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:28 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:30 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
6:32 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:05 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:04 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:06 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:08 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:09 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
5:10 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
8:08 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:53 AM
Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
11/14/2024
5:06 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
7:42 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
2:33 PM
Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
1:10 PM
Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/24/2024
3:44 PM
BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
09/23/2024
5:05 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
5:02 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:42 PM
BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
08/22/2024
7:03 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:05 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:06 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:07 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:09 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:02 PM
Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
5:05 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:57 PM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2024
5:15 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:02 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:04 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:06 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:08 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
5:10 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Greatest "Income Opportunity" of 2025? (Ad)

It has been a wild couple of months so far. And not just in the markets. In our everyday lives. For me, it's highlighted the importance of investment income you can count on…even when life becomes unpredictable. Which is why I've put together this urgent presentation.

05/17/2024
5:01 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
5:26 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
5:01 PM
Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:02 PM
BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:04 PM
Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:06 PM
GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:09 PM
MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:10 PM
O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
5:12 PM
PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:15 PM
Theravance Biopharma (Filer)
Form DEF 14A
04/04/2024
5:09 PM
Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:11 PM
Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:13 PM
Miller Aine (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:15 PM
Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
5:17 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:TBPH) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners